Coronavirus

Lion Air’s aborted IPO has deeper ramifications for capital markets

The delay to Indonesia’s budget carrier’s listing should have investment bankers very worried: the coronavirus now no longer fits the China-only profile but has infected those merely with exposure to it.

Lion Air, Southeast Asia’s second largest low-cost airlines (LCCs), finally joined the increasing list of companies choosing to delay or cancel capital raising activities this year on account of the novel coronavirus. To name two more, Chinese biotech InnoCare, which develops treatments for autoimmune diseases, has delayed investor meetings in Hong Kong, and Japanese restaurant operator Daikiya Group Holdings postponed their plans to go public.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media